NewslettersHuman Immunology NewsUncategorizedSoluble PD-L1 Is a Predictive and Prognostic Biomarker in Advanced Cancer Patients Who Receive Immune Checkpoint Blockade TreatmentBy Justin.choi - October 5, 20210227Researchers investigated the significance of sPD-L1 in cancer patients receiving immune checkpoint inhibitor therapy.[Scientific Reports] 6445218 {6445218:AAAAAAAA} apa 50 1 167507 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article